Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Metabolomics Analysis According to the Thickness of the Retinal Nerve Fiber Layer in Patients With NOHL Mutations

NCT06682819 is registered in ClinicalTrials.gov with Hôpital Necker-Enfants Malades as lead sponsor.

NCT NCT06682819
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06682819 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Metabolomics Analysis According to the Thickness of the Retinal Nerve Fiber Layer in Patients With NOHL Mutations
Lead sponsor
Hôpital Necker-Enfants Malades
Phase
Not applicable
Overall status
Recruiting
Start date
March 10, 2023
Completion date
January 31, 2028
Enrollment
90 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy subjects, leber hereditary optic neuropathy